Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021. Plumb ID, Fette LM, Tjaden AH, Feldstein L, et al. Vaccine 2023 Mar 9:S0264-410X(23)00253-0. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Plumb ID, Fette LM, Tjaden AH, Feldstein L, et al. Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021. Vaccine 2023 Mar 9:S0264-410X(23)00253-0. doi: 10.1016/j.vaccine.2023.
PMID: 36932031